<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
42571-371-87
</NDCCode>
<PackageDescription>
25 VIAL, MULTI-DOSE in 1 CARTON (42571-371-87) > 10 mL in 1 VIAL, MULTI-DOSE (42571-371-88)
</PackageDescription>
<NDC11Code>
42571-0371-87
</NDC11Code>
<ProductNDC>
42571-371
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Succinylcholine Chloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Succinylcholine Chloride
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; INTRAVENOUS
</RouteName>
<StartMarketingDate>
20210301
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA214879
</ApplicationNumber>
<LabelerName>
Micro Labs Limited
</LabelerName>
<SubstanceName>
SUCCINYLCHOLINE CHLORIDE
</SubstanceName>
<StrengthNumber>
200
</StrengthNumber>
<StrengthUnit>
mg/10mL
</StrengthUnit>
<Pharm_Classes>
Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2022-11-10
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210301
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>